STEPHEN HAHN to Paclitaxel
This is a "connection" page, showing publications STEPHEN HAHN has written about Paclitaxel.
Connection Strength
0.213
-
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study. JAMA Oncol. 2017 08 10; 3(8):e172032.
Score: 0.092
-
Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro. Cancer. 1993 Nov 01; 72(9):2705-11.
Score: 0.071
-
Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer. J Clin Oncol. 1998 Feb; 16(2):635-41.
Score: 0.024
-
Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity. Cancer Res. 1993 May 01; 53(9):2066-70.
Score: 0.017
-
Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy. Cancer Chemother Pharmacol. 2003 Sep; 52(3):217-22.
Score: 0.009